Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × ceralasertib × 90 days × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 2 Neoplasms 2 Lung Neoplasms 2 Endometrial Neoplasms 2 Carcinosarcoma 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Advanced Solid Tumours 2 Uterine Cervical Neoplasms 1 Thoracic Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Lung Diseases 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 High Grade Serous Carcinoma 1 Fallopian Tube Neoplasms 1 Extensive Stage Small Cell Lung Cancer 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Endometrioid 1 Carcinoma, Bronchogenic 1 Bronchial Neoplasms 1

Interventions

Cyclophosphamide 21 Rituximab 18 fludarabine 15 obinutuzumab 10 pirtobrutinib 9 fludarabine phosphate 9 venetoclax 8 ibrutinib 7 Prednisone 7 Lenalidomide 7 Biopsy 7 tocilizumab 6 glofitamab 6 Specimen Handling 6 Immunotherapy, Adoptive 6 polatuzumab vedotin 5 Mycophenolic Acid 5 Magnetic Resonance Spectroscopy 5 X-Rays 4 Tacrolimus 4 Phantoms, Imaging 4 Doxorubicin 4 pembrolizumab 3 palbociclib 3 olaparib 3 axicabtagene ciloleucel 3 Whole-Body Irradiation 3 Vincristine 3 Vemurafenib 3 Thiotepa 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡